144 related articles for article (PubMed ID: 1488087)
21. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
22. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
25. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma.
Cobb MA; Husain M; Andersen BJ; al-Mefty O
J Neurosurg; 1996 Jan; 84(1):85-90. PubMed ID: 8613841
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
[TBL] [Abstract][Full Text] [Related]
27. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody analysis of major histocompatibility complex expression in human meningiomas.
Becker I; Roggendorf W
J Neuroimmunol; 1989 Dec; 25(2-3):161-7. PubMed ID: 2584394
[TBL] [Abstract][Full Text] [Related]
29. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.
Fang L; Lowther DE; Meizlish ML; Anderson RC; Bruce JN; Devine L; Huttner AJ; Kleinstein SH; Lee JY; Stern JN; Yaari G; Lovato L; Cronk KM; O'Connor KC
Neuro Oncol; 2013 Nov; 15(11):1479-90. PubMed ID: 23978377
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic change of human cultured meningioma cells.
Pallini R; Casalbore P; Mercanti D; Maggiano N; Larocca LM
J Neurooncol; 2000 Aug; 49(1):9-17. PubMed ID: 11131990
[TBL] [Abstract][Full Text] [Related]
31. Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients.
Ülgen E; Bektaşoğlu PK; Sav MA; Can Ö; Danyeli AE; Hızal DB; Pamir MN; Özduman K
World Neurosurg; 2019 Mar; 123():e520-e535. PubMed ID: 30503291
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical study on HLA-DR expression in human meningiomas.
Ohara N; Hayashi K; Miyake K; Jeon HJ; Takahashi K; Akagi T
Acta Neuropathol; 1992; 84(1):110-2. PubMed ID: 1380199
[TBL] [Abstract][Full Text] [Related]
33. Innate immunity may play a role in growth and relapse of chordoid meningioma.
Presta I; Guadagno E; Di Vito A; Malara N; Mignogna C; Maisano D; Donato A; Cardillo G; Del Basso De Caro ML; Donato G
Int J Immunopathol Pharmacol; 2017 Dec; 30(4):429-433. PubMed ID: 28885077
[TBL] [Abstract][Full Text] [Related]
34. Lipomatous metaplasia occurring within meningiomas--two case reports.
Singh A; Sharma KC
Indian J Pathol Microbiol; 2005 Oct; 48(4):477-8. PubMed ID: 16366099
[TBL] [Abstract][Full Text] [Related]
35. Mast cells in meningiomas and brain inflammation.
Polyzoidis S; Koletsa T; Panagiotidou S; Ashkan K; Theoharides TC
J Neuroinflammation; 2015 Sep; 12():170. PubMed ID: 26377554
[TBL] [Abstract][Full Text] [Related]
36. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
37. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
38. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry.
Lappin DF; Koulouri O; Radvar M; Hodge P; Kinane DF
J Clin Periodontol; 1999 Mar; 26(3):183-9. PubMed ID: 10100045
[TBL] [Abstract][Full Text] [Related]
39. Meningiomas. An immunohistochemical study of 50 cases.
Meis JM; Ordóñez NG; Bruner JM
Arch Pathol Lab Med; 1986 Oct; 110(10):934-7. PubMed ID: 2429637
[TBL] [Abstract][Full Text] [Related]
40. IgG4 overexpression is rare in meningiomas with a prominent inflammatory component: a review of 16 cases.
Lal A; Dahiya S; Gonzales M; Hiniker A; Prayson R; Kleinschmidt-DeMasters BK; Perry A
Brain Pathol; 2014 Jul; 24(4):352-9. PubMed ID: 24467316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
